Signant Health
Mark Watt currently serves as Senior Director of Business Development for Strategic Partners and CRO Partnerships at Signant Health since April 2024. Prior experience includes Associate Director of Global IRT Client Oversight at PPD, where responsibilities included developing IRT bidding strategies and sales solutioning from December 2022 to April 2024. Prior roles at Clario involved leading client success and managing operational oversight for strategic accounts. Mark was also Client/Business Development Manager at Almac Group, overseeing key accounts and managing the end-to-end sales process. Earlier in the career, roles spanned various positions at Norbrook Laboratories Ltd, focusing on pharmaceutical research and development, as well as a clinical conduct role at MDS Pharma Services. Mark holds a BSc Hons in Biology/Biological Sciences from Queen's University Belfast.
This person is not in any teams
This person is not in any offices
Signant Health
2 followers
Signant Health provides clinical technology to help its customers change lives. For more than 20 years, over 400 biopharmaceutical sponsors and CROs of all sizes, including all of the top 20 pharmaceutical organizations, have trusted our patient solutions, clinical supplies platform, and endpoint quality services to capture reliable data, run efficient trials, and uncover meaningful insights.